These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 7512991)

  • 1. Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta.
    Rudnicka L; Varga J; Christiano AM; Iozzo RV; Jimenez SA; Uitto J
    J Clin Invest; 1994 Apr; 93(4):1709-15. PubMed ID: 7512991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta promotes deposition of collagen VII in a modified organotypic skin model.
    König A; Bruckner-Tuderman L
    Lab Invest; 1994 Feb; 70(2):203-9. PubMed ID: 8139261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T; Kähäri VM; Black C; Vuorio E
    J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts.
    Sato M; Shegogue D; Gore EA; Smith EA; McDermott PJ; Trojanowska M
    J Invest Dermatol; 2002 Apr; 118(4):704-11. PubMed ID: 11918720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA TSIX is upregulated in scleroderma dermal fibroblasts and controls collagen mRNA stabilization.
    Wang Z; Jinnin M; Nakamura K; Harada M; Kudo H; Nakayama W; Inoue K; Nakashima T; Honda N; Fukushima S; Ihn H
    Exp Dermatol; 2016 Feb; 25(2):131-6. PubMed ID: 26566700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type VII collagen gene expression by cultured human cells and in fetal skin. Abundant mRNA and protein levels in epidermal keratinocytes.
    Ryynänen J; Sollberg S; Parente MG; Chung LC; Christiano AM; Uitto J
    J Clin Invest; 1992 Jan; 89(1):163-8. PubMed ID: 1729268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
    Man XY; Finnson KW; Baron M; Philip A
    Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of scleroderma. Collagen.
    Jimenez SA; Hitraya E; Varga J
    Rheum Dis Clin North Am; 1996 Nov; 22(4):647-74. PubMed ID: 8923589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of skin fibrosis in systemic sclerosis.
    Jinnin M
    J Dermatol; 2010 Jan; 37(1):11-25. PubMed ID: 20175837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
    Ichiki Y; Smith EA; LeRoy EC; Trojanowska M
    J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
    Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target.
    Piera-Velazquez S; Fertala J; Huaman-Vargas G; Louneva N; Jiménez SA
    Rheumatology (Oxford); 2020 Oct; 59(10):3092-3098. PubMed ID: 32442272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts.
    Ihn H; Yamane K; Tamaki K
    J Invest Dermatol; 2005 Aug; 125(2):247-55. PubMed ID: 16098034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
    Ihn H; Yamane K; Kubo M; Tamaki K
    Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discoidin domain receptor 2-microRNA 196a-mediated negative feedback against excess type I collagen expression is impaired in scleroderma dermal fibroblasts.
    Makino K; Jinnin M; Aoi J; Hirano A; Kajihara I; Makino T; Sakai K; Fukushima S; Inoue Y; Ihn H
    J Invest Dermatol; 2013 Jan; 133(1):110-9. PubMed ID: 22832484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease.
    Tomcik M; Zerr P; Palumbo-Zerr K; Storkanova H; Hulejova H; Spiritovic M; Kodet O; Stork J; Becvar R; Vencovsky J; Pavelka K; Filkova M; Distler JH; Senolt L
    Rheumatology (Oxford); 2015 Dec; 54(12):2273-82. PubMed ID: 26231346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.
    Zerr P; Palumbo-Zerr K; Huang J; Tomcik M; Sumova B; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2016 Jan; 75(1):226-33. PubMed ID: 25180292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts.
    Yamane K; Ihn H; Kubo M; Tamaki K
    Arthritis Rheum; 2002 Sep; 46(9):2421-8. PubMed ID: 12355490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.